Plain-English translation of NCT05029531 on ClinicalTrials.gov ↗ · Source last updated ·
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a combination chemotherapy treatment plan for infants (babies under 1 year old) who have been newly diagnosed with acute lymphoblastic leukemia, a serious blood cancer. The treatment uses several chemotherapy drugs given in a specific sequence over many months. Your baby's treatment plan will be personalized based on how well the leukemia responds to the initial therapy.
Acute lymphoblastic leukemia in infants is very serious and requires aggressive treatment, but babies have special medical needs that differ from older children. This trial aims to improve survival and outcomes by using a carefully designed combination approach tailored specifically for this very young age group.
You likely qualify if…
You likely don't qualify if…
Your baby will receive intensive chemotherapy over several months, starting with an induction phase lasting 36 days that includes daily steroids, weekly injections, and spinal injections of medications. After the first phase, treatment continues with additional chemotherapy cycles, the specific plan depending on how well your baby's leukemia responds. You and your baby will visit one of the participating clinics regularly for treatments, blood tests, and monitoring of side effects throughout the entire treatment period.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Russia